Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-981 in advanced solid tumors and CD20+ NHL
CTR20213021Phase 2Terminated
- Sponsor
- Takeda
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of subasumstat in Non-small cell lung cancer (NS-NSCLC), Cervical Cancer (CC), colorectal cancer (CRC), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), sponsored by Takeda. Started Dec 2021; status: terminated.
02
Drugs
subasumstat
03
Conditions
Non-small cell lung cancer (NS-NSCLC)Cervical Cancer (CC)colorectal cancer (CRC)diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)
Beyond the preview
Go deeper on CTR20213021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213021.